{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:15:38Z","timestamp":1761894938349,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.ahj.2009.06.023","type":"journal-article","created":{"date-parts":[[2009,8,23]],"date-time":"2009-08-23T04:23:38Z","timestamp":1251001418000},"page":"378-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Use of \u03b2-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: Are we on target?"],"prefix":"10.1016","volume":"158","author":[{"given":"Michael","family":"Herman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maichi","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigid","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis A.","family":"Tighe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2009.06.023_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM198104023041401","article-title":"Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction","volume":"304","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2009.06.023_bib2","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A randomized trial of propranolol in patients with acute myocardial infarction: mortality results","volume":"247","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2009.06.023_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmj.284.6310.155","article-title":"One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian Multicentre Trial","volume":"284","author":"Hansteen","year":"1982","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2009.06.023_bib4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"The CAPRICORN Investigators","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2009.06.023_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","article-title":"Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction","volume":"339","author":"Gottlieb","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2009.06.023_bib6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.1993.03510130095038","article-title":"Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials","volume":"270","author":"Teo","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2009.06.023_bib7","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2009.06.023_bib8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0140-6736(81)91101-6","article-title":"Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial","volume":"2","author":"Hjalmarson","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2009.06.023_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(84)90651-2","article-title":"Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol","volume":"2","author":"Norris","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2009.06.023_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.eurheartj.a061845","article-title":"A randomised placebo-controlled international trial. The MIAMI Trial Research Group","volume":"6","author":"Metoprolol in acute myocardial infarction (MIAMI)","year":"1985","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2009.06.023_bib11","first-page":"57","article-title":"Randomized trial of intravenous atenolol among 16\u00a0027 cases of suspected acute myocardial infarction. ISIS-1","volume":"2","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2009.06.023_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ahj.2009.06.023_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.83.2.422","article-title":"Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) II-B study","volume":"83","author":"Roberts","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2009.06.023_bib14","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0735-1097(98)00279-4","article-title":"Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience","volume":"32","author":"Pfisterer","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib15","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2009.06.023_bib16","doi-asserted-by":"crossref","first-page":"43F","DOI":"10.1016\/0002-9149(86)90888-X","article-title":"Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials","volume":"57","author":"Kjekshus","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198807213190306","article-title":"Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after myocardial infarction","volume":"319","author":"Goldman","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2009.06.023_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0002-9149(96)00820-X","article-title":"Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prevention Secondaire de l'Infarctus","volume":"79","author":"Cucherat","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.107.188209","volume":"117","author":"Antman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2009.06.023_bib20","first-page":"el","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib21","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Guidelines for the diagnosis and treatment of non\u2013ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non\u2013ST-segment elevation acute coronary syndromes of the European Society of Cardiology","volume":"28","author":"Bassand","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2009.06.023_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0195-668X(02)00618-8","article-title":"Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology","volume":"24","author":"Van de Werf","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2009.06.023_bib23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2004.07.014","volume":"44","author":"Antman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9149(86)90234-1","article-title":"Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest","volume":"58","author":"Gundersen","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0002-9149(90)91029-6","article-title":"Influence of heart rate on mortality after myocardial infarction","volume":"65","author":"Hjalmarson","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib26","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","article-title":"Joint ESC\/ACCF\/AHA\/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction","volume":"50","author":"Thygesen","year":"2007","journal-title":"J Am Coll Cardiol"},{"author":"Acute Myocardial Infarction Core Measure Set","key":"10.1016\/j.ahj.2009.06.023_bib27"},{"key":"10.1016\/j.ahj.2009.06.023_bib28","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/0002-9149(83)90224-2","article-title":"First ultra-short-acting beta-adrenergic blocking agent: its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs","volume":"51","author":"Lange","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib29","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0735-1097(10)80151-2","article-title":"Acute effects of parenteral beta-blockade on regional ventricular function of infarct and noninfarct zones after reperfusion therapy in humans","volume":"17","author":"Grines","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib30","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/oxfordjournals.eurheartj.a062348","article-title":"Beta-adrenergic blockade in acute myocardial infarction: a hemodynamic and radionuclide study","volume":"8","author":"Murray","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2009.06.023_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0735-1097(93)90044-2","article-title":"Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy","volume":"22","author":"Van der Werf","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib32","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0735-1097(94)00552-2","article-title":"Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice","volume":"25","author":"Viskin","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jama.280.7.623","article-title":"National use and effectiveness of \u03b2-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project","volume":"280","author":"Krumholz","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2009.06.023_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/jama.1997.03540260029031","article-title":"Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction","volume":"277","author":"Soumerai","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2009.06.023_bib35","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0735-1097(02)02379-3","article-title":"Outpatient adherence to beta-blocker therapy after acute myocardial infarction","volume":"40","author":"Butler","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib36","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archinte.160.7.947","article-title":"Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?","volume":"160","author":"Chen","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2009.06.023_bib37","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0735-1097(99)00383-6","article-title":"Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients: results from the National Cooperative Cardiovascular Project","volume":"34","author":"Chen","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib38","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0735-1097(01)01225-6","article-title":"Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma","volume":"37","author":"Chen","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2009.06.023_bib39","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870309004785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870309004785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:39:32Z","timestamp":1757569172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870309004785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0002870309004785"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2009.06.023","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of \u03b2-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: Are we on target?","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2009.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}